查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519370

2024-2032 年按產品類型、給藥途徑、劑型、配銷通路和地區分類的非處方藥市場報告

Over The Counter Drugs Market Report by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年全球非處方藥（OTC）IMARC Group規模達1,687億美元。

非處方藥 (OTC) 也稱為非處方藥，無需處方或無需尋求醫療保健專業人員的治療即可使用。它們安全有效，有助於治療疼痛、咳嗽和感冒、腹瀉、便秘、痤瘡，並控制反覆發作的偏頭痛和過敏。目前，它們在全球各地的藥局、便利商店、超市和加油站均有販售。

非處方 (OTC) 藥品市場趨勢：

擴大使用非處方藥來治療個人小病是推動市場成長的關鍵因素之一。除此之外，制酸劑、組織胺 2 (H2) 阻斷劑和質子幫浦抑制劑 (PPI) 等非處方藥可用於緩解和預防胃灼熱或酸性消化不良。此外，由於冠狀病毒病（COVID-19）的爆發，人們對自我保健重要性的認知有所提高。這反過來又增加了營養補充劑的銷售量並加強了市場成長。此外，主要參與者正在擴大其產品組合，以擴大其消費者基礎並擴大其地理影響力。再加上監管機構擴大批准將處方藥轉向非處方藥，正在對市場產生積極影響。除此之外，由於醫療費用增加，目前選擇非處方藥而不是諮詢醫生的人數增加。此外，自我藥療可以幫助控制慢性病，減少缺勤，並節省稀缺的醫療資源，以免在輕微情況下耗盡。其他一些因素，例如全球老年人口的增加、分銷管道的快速擴張以及製藥行業的顯著成長，正在推動整體銷售額和盈利能力。

本報告回答的關鍵問題

  • 2023 年全球非處方藥 (OTC) 市場規模？
  • 2024-2032年全球非處方藥（OTC）市場的預期成長率是多少？
  • 推動全球非處方藥（OTC）市場發展的關鍵因素是什麼？
  • COVID-19 對全球非處方藥 (OTC) 市場有何影響？
  • 根據產品類型，全球非處方藥 (OTC) 市場的詳細情形如何？
  • 根據給藥途徑，全球非處方藥 (OTC) 市場的細分如何？
  • 全球非處方藥（OTC）市場按劑型分類是怎樣的？
  • 全球非處方藥 (OTC) 藥品市場按配銷通路分類是怎樣的？
  • 全球非處方藥（OTC）市場的主要區域有哪些？
  • 全球非處方 (OTC) 藥品市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球非處方 (OTC) 藥品市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品類型

  • 咳嗽、感冒和流感產品
    • 市場走向
    • 市場預測
  • 止痛藥
    • 市場走向
    • 市場預測
  • 皮膚科產品
    • 市場走向
    • 市場預測
  • 腸胃產品
    • 市場走向
    • 市場預測
  • 維生素、礦物質和補充劑 (VMS)
    • 市場走向
    • 市場預測
  • 減肥/膳食產品
    • 市場走向
    • 市場預測
  • 眼科產品
    • 市場走向
    • 市場預測
  • 安眠藥
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依管理途徑

  • 口服
    • 市場走向
    • 市場預測
  • 注射用
    • 市場走向
    • 市場預測
  • 專題
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：按劑型

  • 片劑和膠囊
    • 市場走向
    • 市場預測
  • 液體
    • 市場走向
    • 市場預測
  • 藥膏
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥局
    • 市場走向
    • 市場預測
  • 網路藥局
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Alkem Laboratories Limited
    • Bayer AG
    • Daiichi Sankyo Company Limited
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Novartis AG
    • Perrigo Company plc
    • Pfizer Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser Group PLC
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A5189

The global over the counter (OTC) drugs market size reached US$ 168.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 275.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032.

Over the counter (OTC) drugs, also known as non-prescription drugs, can be used without a prescription or the need for seeking treatment by a healthcare professional. They are safe and effective and help cure pain, cough and cold, diarrhea, constipation, acne and manage recurring migraines and allergies. They are currently available in pharmacies, convenience stores, supermarkets and gas stations across the globe.

Over The Counter (OTC) Drugs Market Trends:

The increasing utilization of OTC drugs to treat minor ailments among individuals represents one of the key factors bolstering the market growth. Besides this, OTC medications, such as antacids, histamine-2 (H2) blockers, and proton pump inhibitors (PPIs), are used to relieve and prevent heartburn or acid indigestion. In addition, due to the coronavirus disease (COVID-19) outbreak, there is a rise in awareness among individuals about the importance of self-care. This, in turn, is increasing the sales of nutritional supplements and strengthening the market growth. Moreover, key players are expanding their product portfolio to widen their consumer base and increase their geographical presence. This, coupled with the increasing approvals from regulatory bodies for switching prescription drugs to OTC drugs, is positively influencing the market. Apart from this, there is currently an increase in the number of people opting for OTC drugs rather than consulting physicians on account of increasing healthcare costs. Furthermore, self-medication practices can assist in controlling chronic diseases, reducing absenteeism from work, and saving scarce medical resources from being exhausted during minor conditions. Some of the other factors, such as the rising geriatric population worldwide, rapid expansion of distribution channels, and significant growth in the pharmaceutical industry, are driving the overall sales and profitability.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global over the counter (OTC) drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, route of administration, dosage form, and distribution channel.

Breakup by Product Type:

Cough, Cold and Flu Products

Analgesics

Dermatology Products

Gastrointestinal Products

Vitamins, Minerals and Supplements (VMS)

Weight-loss/Dietary Products

Ophthalmic Products

Sleeping Aids

Others

Breakup by Route of Administration:

Oral

Parenteral

Topical

Others

Breakup by Dosage Form:

Tablets and Capsules

Liquids

Ointments

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Alkem Laboratories Limited, Bayer AG, Daiichi Sankyo Company Limited, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1. What was the size of the global over the counter (OTC) drugs market in 2023?
  • 2. What is the expected growth rate of the global over the counter (OTC) drugs market during 2024-2032?
  • 3. What are the key factors driving the global over the counter (OTC) drugs market?
  • 4. What has been the impact of COVID-19 on the global over the counter (OTC) drugs market?
  • 5. What is the breakup of the global over the counter (OTC) drugs market based on the product type?
  • 6. What is the breakup of the global over the counter (OTC) drugs market based on the route of administration?
  • 7. What is the breakup of the global over the counter (OTC) drugs market based on the dosage form?
  • 8. What is the breakup of the global over the counter (OTC) drugs market based on the distribution channel?
  • 9. What are the key regions in the global over the counter (OTC) drugs market?
  • 10. Who are the key players/companies in the global over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Over The Counter (OTC) Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Analgesics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Dermatology Products
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Gastrointestinal Products
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Ophthalmic Products
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Sleeping Aids
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast
  • 6.9 Others
    • 6.9.1 Market Trends
    • 6.9.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquids
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ointments
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Alkem Laboratories Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Daiichi Sankyo Company Limited
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 GlaxoSmithKline plc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Novartis AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Perrigo Company plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Enterprises Ltd.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Reckitt Benckiser Group PLC
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Sanofi S.A.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Sun Pharmaceutical Industries Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
    • 15.3.14 Teva Pharmaceutical Industries Ltd.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Over The Counter Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Over The Counter Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Over The Counter Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Over The Counter Drugs Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Over The Counter Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Over The Counter Drugs Market: Breakup by Dosage Form (in %), 2023
  • Figure 7: Global: Over The Counter Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 8: Global: Over The Counter Drugs Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Over The Counter Drugs (Cough, Cold and Flu Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Over The Counter Drugs (Analgesics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Over The Counter Drugs (Analgesics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Over The Counter Drugs (Dermatology Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Over The Counter Drugs (Dermatology Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Over The Counter Drugs (Gastrointestinal Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Over The Counter Drugs (Gastrointestinal Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Over The Counter Drugs (Vitamins, Minerals and Supplements (VMS)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Over The Counter Drugs (Weight-loss/Dietary Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Over The Counter Drugs (Ophthalmic Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Over The Counter Drugs (Ophthalmic Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Over The Counter Drugs (Sleeping Aids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Over The Counter Drugs (Sleeping Aids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Over The Counter Drugs (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Over The Counter Drugs (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Over The Counter Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Over The Counter Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Over The Counter Drugs (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Over The Counter Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Over The Counter Drugs (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Over The Counter Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Over The Counter Drugs (Other Route of Administrations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Over The Counter Drugs (Other Route of Administrations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Over The Counter Drugs (Tablets and Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Over The Counter Drugs (Tablets and Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Over The Counter Drugs (Liquids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Over The Counter Drugs (Liquids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Over The Counter Drugs (Ointments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Over The Counter Drugs (Ointments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Over The Counter Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Over The Counter Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Over The Counter Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Over The Counter Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Over The Counter Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Over The Counter Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Over The Counter Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Over The Counter Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Over The Counter Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Over The Counter Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: North America: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: North America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United States: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United States: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Canada: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Canada: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia-Pacific: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia-Pacific: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Europe: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Europe: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Germany: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Germany: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: France: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: France: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: United Kingdom: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: United Kingdom: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Italy: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Italy: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Spain: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Spain: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Russia: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Russia: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Latin America: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Latin America: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Brazil: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Brazil: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Mexico: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Mexico: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Others: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Others: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Middle East and Africa: Over The Counter Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Middle East and Africa: Over The Counter Drugs Market: Breakup by Country (in %), 2023
  • Figure 99: Middle East and Africa: Over The Counter Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Global: Over The Counter Drugs Industry: SWOT Analysis
  • Figure 101: Global: Over The Counter Drugs Industry: Value Chain Analysis
  • Figure 102: Global: Over The Counter Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Over The Counter Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Over The Counter Drugs Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Over The Counter Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Over The Counter Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2024-2032
  • Table 5: Global: Over The Counter Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 6: Global: Over The Counter Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Over The Counter Drugs Market: Competitive Structure
  • Table 8: Global: Over The Counter Drugs Market: Key Players